Atlas Trials

Comparison of Etamsylate Versus Placebo to Prevent Bleeding in HSCT

Clinical trial NCT07442513 · RECRUITING

Trial details

NCT number
NCT07442513
Sponsor
First Affiliated Hospital of Zhejiang University
Status
RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Hematopoietic Stem Cell TransplantationThrombocytopenia
Start date
2025-12-16
Primary completion
2027-10-31
Enrollment
404

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.